Stocks Health care TRLV
NYSE · Health careTrulieve Cannabis Corp. (TRLV)
Trulieve Cannabis Corp. brought in $1.1B of revenue over the twelve months to September 30, 2026, down 9.1% from a year earlier. It posted a net loss of $445.6M. Operating cash flow minus capital spending left $228.6M of free cash flow in fiscal 2025. At September 30, 2026 it held $326.7M in cash against $196M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Trulieve Cannabis Corp.
- Net worth
- Trulieve Cannabis Corp. has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $771.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.2B (-0.4% year on year), with a net loss of $116.4M. Over the 12 months to September 30, 2026: revenue $1.1B, net loss $445.6M.
- Cash flow
- In fiscal 2025 operations brought in $272.8M of cash; after $44.2M of capital spending, free cash flow was $228.6M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Trulieve Cannabis Corp.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Trulieve Cannabis Corp. does
Trulieve Cannabis Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NYSE under the ticker TRLV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.2B | -$116.4M | -$0.58 | $228.6M |
| 2024 | $1.2B | -$155.1M | -$0.79 | $148.9M |
| 2023 | $1.1B | -$526.8M | -$2.28 | $161.6M |
| 2022 | $1.2B | -$252.7M | -$0.95 | -$141.7M |
| 2021 | $931.9M | $17.4M | $0.21 | -$263M |
| 2021 | $521.5M | $63M | $0.93 | -$298K |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where TRLV ranks in Health care
Latest SEC filings
What Trulieve Cannabis Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 20% to $230.2M versus the same quarter last year; diluted EPS $0.00 versus -$0.14.
- November 5, 2026
- August 24, 2026Form S-8 POS filing S-8 POS
- August 24, 2026Form POSASR filing POSASR
- August 11, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 10% to $271M versus the same quarter last year; net loss of $406M.
- August 7, 2026
- August 5, 2026
- July 8, 2026Passive stake (5% or more) SCHEDULE 13G
- July 2, 2026
What is TRLV worth? A DCF from its reported cash flow
Insider trades
What the people running Trulieve Cannabis Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 26, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 136,811 | $1.2M |
| June 25, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 300,000 | $2.5M |
| June 24, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 400,000 | $3.3M |
| June 23, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 380,000 | $3.2M |
| June 22, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 204,815 | $1.9M |
| June 18, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 139,846 | $1.3M |
| June 17, 2026 | Rivers Kim A.Chairman and CEO, Director, 10% owner | Soldpre-planned (10b5-1) | 137,535 | $1.3M |
| March 13, 2026 | Millner Thomas LDirector | Received as pay | 23,438 | - |
Who owns TRLV
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| AdvisorShares Trust13G, passive | 6.26% | July 8, 2026 |
| Marex Securities Products Inc.13G, passive with 1 related filers | 5.8% | December 18, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 125 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| AdvisorShares Investments LLC | 10,641,152 | new |
| Cantor Fitzgerald, L. P. | 7,500,000 | new |
| Nomura Holdings Inc | 5,065,849 | new |
| Marex Group Ltd | 3,250,000 | new |
| Ing Groep NV | 2,665,000 | new |
| Jane Street Group, LLC | 1,212,526 | new |
| Picton Mahoney Asset Management | 838,088 | new |
| Anson Funds Management LP | 524,500 | new |
| Verition Fund Management LLC | 500,000 | new |
| Montanova Capital, LLC | 356,100 | new |
| Murchinson Ltd. | 355,200 | new |
| Purpose Unlimited Inc. | 342,560 | new |
| Cresset Asset Management, LLC | 284,488 | new |
| Proficio Capital Partners LLC | 201,931 | new |
| Manatuck Hill Partners, LLC | 200,000 | new |
| NewGen Asset Management Ltd | 200,000 | new |
| HighTower Advisors, LLC | 156,492 | new |
| Old Mission Capital LLC | 149,391 | new |
| Formula Growth Ltd | 120,000 | new |
| Nano Cap New Millennium Growth Fund L P | 120,000 | -25,000 |
Insiders
17 insiders reported holding 6,784,594 shares in total, about $74.7M at the last price.
| Holder | Shares |
|---|---|
| Beshears ThadDirector | 2,487,043 |
| Rivers Kim A.Chairman and CEO, Director, 10% owner | 1,476,913 |
| May Richard S.Director | 593,534 |
| Pernell JasonPresident | 581,795 |
| Landrum KyleChief Production Officer | 258,776 |
| Powers EricChief Legal Officer | 245,311 |
| Jhala NilyumChief Technology Officer | 239,254 |
| Morey TimothyChief Sales Officer | 174,709 |
| Hersey Christine AnnChief Corp Affairs & Strategy | 143,767 |
| Walsh Brett R.Chief Accounting Officer | 140,305 |
Questions about TRLV
What does Trulieve Cannabis Corp. do?
Trulieve Cannabis Corp. is a company in the Health care sector, listed on NYSE as TRLV. Its shares trade on NYSE under the ticker TRLV.
What is Trulieve Cannabis Corp.'s net worth?
Trulieve Cannabis Corp. has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $771.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Trulieve Cannabis Corp. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $445.6M on revenue of $1.1B.
How much revenue does Trulieve Cannabis Corp. make?
Over the twelve months to September 30, 2026 Trulieve Cannabis Corp. reported revenue of $1.1B. That is 9.1% less than a year earlier.
When did Trulieve Cannabis Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Trulieve Cannabis Corp.'s next earnings report?
Trulieve Cannabis Corp.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare TRLV with
Follow TRLV
Get an email when Trulieve Cannabis Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Trulieve Cannabis Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.